Head and Neck Cancer


  • Xospata Extends Overall Survival in Patients with FLT3 Mutation–Positive Relapsed or Refractory Acute Myeloid Leukemia
  • Published Results from KEYNOTE-048 Trial Show Extended Survival with Keytruda in Advanced Head and Neck Cancers
  • Discussing Costs of Genomic Testing with Patients
Read More ›

San Francisco, CA—The increasing rate of infection with the human papilloma­virus (HPV) in the United States has changed the field of head and neck cancer, or oral cancer, and HPV infection now causes a growing majority (70%-90%) of oropharyngeal squamous-cell carcinomas. As its incidence is rising, so is patients’ curiosity about what sets this cancer apart from other malignancies. Read More ›

Low Survival in Patients with Head and Neck Cancers Linked to Delays in Radiation Therapy After Surgery

According to data presented at the 2018 Multidisciplinary Head and Neck Cancers Symposium, a shorter interval from surgery to the start of radiation therapy has been linked to improved survival in patients with head and neck cancers.

Read More ›

Gaps Found in Nutritional Care for Patients with Head and Neck Cancer
Patients with head and neck cancer are at a high risk for malnutrition, but use of a best practice model for nutritional support can improve outcomes and address unmet needs. Read More ›

Proper attention to dental care for patients with head and neck cancer can mean the difference between a good functional outcome and a poor one, according to a dental oncologist and nurse who described dental oncology at the Oncology Nursing Society 41st Annual Congress. Read More ›

Comprehensive genetic analysis by The Cancer Genome Atlas (TCGA) identified 4 different subtypes of squamous cell carcinoma of the head and neck (SCCHN). Read More ›

Sentinel lymph node (SLN) biopsy, a common procedure to determine whether melanoma has spread, can be utilized safely and effectively even with tumors in the head and neck area according to a new study from the University of Michigan Comprehensive Cancer Center.

SLN biopsy is routinely offered to patients with melanoma meeting or exceeding a certain size. However, many surgeons believed the intricate anatomy combined with the crucial nerves and blood vessels in the head and neck area created an unsafe and inaccurate setting for an SLN biopsy of that region.

Read More ›

Concomitant chemotherapy with reirradiation offers a cure for select patients with recurrent head and neck cancer in a previously irradiated area. With the findings of 2-year survival in 25% of patients, the researchers noted the importance of choosing the correct patients for this therapy. Previous concurrent chemoradiotherapy was associated with poor survival outcomes. In addition, there was significant risk of sever toxicity, with 20% of patients experiencing treatment-related death.

 

Read More ›

Today, plastic surgery has achieved great strides in restoring appearance and function.1 In patients with cancer, reconstructive surgery must allow for adequate resection of tumor with clear margins, facilitate initiation of adjuvant therapy, and maximize quality of life by making the most of function and esthetics. Read More ›


Subscribe to The Oncology Nurse-APN/PA

To sign up for our newsletter or print publications, enter your contact information below.

I'd like to receive: